SENSEX 76332.75 (0.05)
Nifty 50 23080.5 (0.04)
Nifty Bank 49564.35 (0.33)
Nifty IT 41796.9 (-0.41)
Nifty Midcap 100 50927.3 (0.08)
Nifty Next 50 60987.75 (0.26)
Nifty Pharma 21213.5 (-0.17)
Nifty Smallcap 100 16082.45 (0.05)
NIKKEI 225 38963.7 (0.42)
HANG SENG 21822.59 (2.48)
S&P 6099.5 (-0.08)
BSE Code : 524816 | NSE Symbol : NATCOPHARM | ISIN : INE987B01026 | Industry : Pharmaceuticals |
Hot Pursuit 10-Feb-2025 (10:39) NATCO Pharma gets final approval for its ANDA for Bosentan tablets
Corporate News 10-Feb-2025 (09:16) Natco Pharma receives USFDA approval for Bosentan tablets for oral suspension, 32mg
Hot Pursuit 06-Feb-2025 (13:06) Natco Pharma Ltd soars 3.15%, up for third straight session
Corporate News 31-Jan-2025 (10:24) Natco Pharma to hold board meeting
Hot Pursuit 30-Jan-2025 (12:57) NATCO Pharma gets approval for its ANDA for Everolimus tablets
Natco Pharma 13-Nov-2024
Natco Pharma 13-Aug-2024
Natco Pharma 28-May-2024
Total Foreign
Total Institutions
Total Govt Holding
Total Non Promoter Corporate Holding
Total Promoters
Total Public & others